In a recent study, we were able to show that an oral challenge of secondary abiotic IL-10−/− mice with carvacrol in a prophylactic regimen starting four days prior C. jejuni infection resulted in lowered intestinal pathogen loads and alleviated symptoms of acute campylobacteriosis [53]. The gene discussed is IL10; the disease is campylobacteriosis.